These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 14169967

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. ACTIVATION PRODUCT, FACTOR IX, SERUM THROMBOTIC ACCELERATOR ACTIVITY, AND SERUM-INDUCED THROMBOSIS.
    DEYKIN D, WESSLER S.
    J Clin Invest; 1964 Feb; 43(2):160-6. PubMed ID: 14162524
    [No Abstract] [Full Text] [Related]

  • 3. Pathogenesis of venous thrombosis in relation to its prevention by dextran and heparin.
    Gurewich V, Thomas DP.
    J Lab Clin Med; 1965 Oct; 66(4):604-12. PubMed ID: 5843088
    [No Abstract] [Full Text] [Related]

  • 4. ROLES OF SURFACE FACTOR AND A PLASMA INHIBITORY ACTIVITY (ANTI-SF) DURING EXPERIMENTAL THROMBOSIS IN RABBITS.
    IATRIDIS SG, IATRIDIS PG, FERGUSON JH.
    Thromb Diath Haemorrh; 1964 Dec 31; 12():489-504. PubMed ID: 14254706
    [No Abstract] [Full Text] [Related]

  • 5. THE ACTIVATION AND CONSUMPTION OF FACTOR IX.
    NOSSEL HL.
    Thromb Diath Haemorrh; 1964 Dec 31; 12():505-9. PubMed ID: 14254707
    [No Abstract] [Full Text] [Related]

  • 6. ROLE OF FACTORS XII, XI, AND IX IN SERUM AND PLASMA-INDUCED THROMBOSIS.
    REIMER SM, THOMAS DP.
    Am J Physiol; 1963 Dec 31; 205():1265-9. PubMed ID: 14084997
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Clinical and experimental studies on the contact factor. II. Experimental studies on the thrombotic activity of activation product].
    Ito M.
    Nihon Ketsueki Gakkai Zasshi; 1968 Dec 31; 31(7):1155-64. PubMed ID: 5753796
    [No Abstract] [Full Text] [Related]

  • 11. [BLOOD CLOTTING FACTOR IN HEMOLYSATES].
    OGIWARA Y.
    Nihon Ketsueki Gakkai Zasshi; 1963 Dec 31; 26():779-87. PubMed ID: 14154695
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. IgE-induced blood coagulation alterations in the rabbit: consumption of coagulation factors XII, XI, and IX in vivo.
    Pinckard RN, Tanigawa C, Halonen M.
    J Immunol; 1975 Aug 31; 115(2):525-32. PubMed ID: 50367
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. NATURE AND ACTION OF INTERMEDIATE PRODUCT I.
    SPAET TH.
    Fed Proc; 1964 Aug 31; 23():757-61. PubMed ID: 14195459
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Coagulation changes following injection of a purified contact activation product].
    Barth P, Czygan P, Zimmermann R.
    Verh Dtsch Ges Inn Med; 1971 Aug 31; 77():1029-32. PubMed ID: 5155957
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.